141 related articles for article (PubMed ID: 25305404)
1. Urinary nerve growth factor in patients with symptomatic detrusor overactivity.
Agilli M; Aydin FN; Cayci T
Am J Obstet Gynecol; 2015 Feb; 212(2):251-2. PubMed ID: 25305404
[No Abstract] [Full Text] [Related]
2. Reply: To PMID 25019486.
Pillalamarri N; Shalom DF
Am J Obstet Gynecol; 2015 Feb; 212(2):252. PubMed ID: 25305405
[No Abstract] [Full Text] [Related]
3. Sacral nerve stimulation reduces elevated urinary nerve growth factor levels in women with symptomatic detrusor overactivity.
Shalom DF; Pillalamarri N; Xue X; Kohn N; Lind LR; Winkler HA; Metz CN
Am J Obstet Gynecol; 2014 Nov; 211(5):561.e1-5. PubMed ID: 25019486
[TBL] [Abstract][Full Text] [Related]
4. The role of electrical stimulation techniques in the management of the male patient with urgency incontinence.
Johnsen NV; Osborn DJ; Dmochowski RR
Curr Opin Urol; 2014 Nov; 24(6):560-5. PubMed ID: 25144143
[TBL] [Abstract][Full Text] [Related]
5. Sacral Nerve Stimulation as a Therapy for Patients With Refractory Voiding and Bowel Dysfunction.
Noblett KL; Buono K
Obstet Gynecol; 2018 Dec; 132(6):1337-1345. PubMed ID: 30399090
[TBL] [Abstract][Full Text] [Related]
6. Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence.
Groenendijk PM; Lycklama à Nyeholt AA; Heesakkers JP; van Kerrebroeck PE; Hassouna MM; Gajewski JB; Cappellano F; Siegel SW; Fall M; Dijkema HE; Jonas U; van den Hombergh U;
BJU Int; 2008 Feb; 101(3):325-9. PubMed ID: 18070199
[TBL] [Abstract][Full Text] [Related]
7. Urethral instability and sacral nerve stimulation-a better parameter to predict efficacy?
Groenendijk PM; Heesakkers JP; Lycklama A Nijeholt AA
J Urol; 2007 Aug; 178(2):568-72; discussion 572. PubMed ID: 17570438
[TBL] [Abstract][Full Text] [Related]
8. [NERVE GROWTH FACTOR IN THE URINE OF PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND OVERACTIVE BLADDER WITHOUT DETRUSOR OVERACTIVITY].
Krivoborodov GG; Kolesanova EF; Tur EI; Efremov NS
Urologiia; 2015; (3):19-22. PubMed ID: 26390554
[TBL] [Abstract][Full Text] [Related]
9. Sacral nerve stimulation for urinary control.
Clin Privil White Pap; 2011 Oct; (227):1-14. PubMed ID: 22003580
[No Abstract] [Full Text] [Related]
10. Percutaneous tibial nerve stimulation for the treatment of voiding dysfunction.
Technol Eval Cent Assess Program Exec Summ; 2011 Mar; 25(8):1-7. PubMed ID: 21638944
[No Abstract] [Full Text] [Related]
11. Clinical practice. Idiopathic urgency urinary incontinence.
Nygaard I
N Engl J Med; 2010 Sep; 363(12):1156-62. PubMed ID: 20843250
[No Abstract] [Full Text] [Related]
12. Outcomes of Sacral Neuromodulation in Patients with Prior Surgical Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse.
Bartley JM; Ramirez V; Killinger KA; Boura JA; Gupta P; Gaines N; Gilleran JP; Peters KM
Female Pelvic Med Reconstr Surg; 2017; 23(1):8-12. PubMed ID: 27636222
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous tibial nerve stimulation for treatment of overactive bladder and urinary retention in an elderly population.
Zinkgraf K; Quinn AO; Ketterhagen D; Kreuziger B; Stevenson K
Urol Nurs; 2009; 29(1):30-4. PubMed ID: 19331273
[TBL] [Abstract][Full Text] [Related]
14. [Anticholinergic drugs versus non-drug treatment of overactive bladder syndrome in adults. A survey of a Cochrane review].
Nordling J
Ugeskr Laeger; 2007 Dec; 169(50):4345-7. PubMed ID: 18211791
[No Abstract] [Full Text] [Related]
15. Will posterior tibial nerve stimulation replace sacral nerve root stimulation as the salvage management of drug resistant urinary urge incontinence?
Doggweiler R
J Urol; 2010 Nov; 184(5):1835-6. PubMed ID: 20846687
[No Abstract] [Full Text] [Related]
16. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.
Peters KM; Carrico DJ; Wooldridge LS; Miller CJ; MacDiarmid SA
J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541
[TBL] [Abstract][Full Text] [Related]
17. Neuromodulative treatment with percutaneous tibial nerve stimulation for intractable detrusor instability: outcomes following a shortened 6-week protocol.
Yoong W; Ridout AE; Damodaram M; Dadswell R
BJU Int; 2010 Dec; 106(11):1673-6. PubMed ID: 20590544
[TBL] [Abstract][Full Text] [Related]
18. Increased urinary nerve growth factor as a predictor of persistent detrusor overactivity after bladder outlet obstruction relief in a rat model.
Lee SR; Hong CH; Choi YD; Kim JH
J Urol; 2010 Jun; 183(6):2440-4. PubMed ID: 20403616
[TBL] [Abstract][Full Text] [Related]
19. Increasing patient preparedness for sacral neuromodulation improves patient reported outcomes despite leaving objective measures of success unchanged.
Firoozi F; Gill B; Ingber MS; Moore CK; Rackley RR; Goldman HB; Vasavada SP
J Urol; 2013 Aug; 190(2):594-7. PubMed ID: 23499745
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of nerve growth factor in detrusor overactivity: a study on women with mixed urinary incontinence.
Salehi-Pourmehr H; Ghojazadeh M; Jahantabi E; Hajebrahimi S
Int Urol Nephrol; 2021 Aug; 53(8):1557-1562. PubMed ID: 33866484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
